Bioorganic and Medicinal Chemistry Letters p. 333 - 336 (1999)
Update date:2022-08-04
Topics:
Le Borgne, Marc
Marchand, Pascal
Delevoye-Seiller, Benedicte
Robert, Jean-Michel
Le Baut, Guillaume
Hartmann, Rolf W.
Palzer, Martina
Six azolyl substituted indoles were synthesized and tested for their activity to inhibit two P450 enzymes: P450 arom and P450 17α. It was observed that the introduction of α-imidazolylbenzyl chain at carbon 3 or 5 on indole nucleus led to very active molecules. Compounds 22, 23 and especially 33 demonstrate very high potential against P450 arom. Under our assay conditions of high substrate concentration the IC50 are 0.057, 0.0785 and 0.041 μM, respectively. These compounds are moderate inhibitors against P450 17α.
View MoreYurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
AstaTech ( Chengdu) BioPharmaceutical Corp.
website:http://www.astabiochem.cn/
Contact:+86-15198215156-15198215156
Address:SICHUAN CHENGDU
Contact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Doi:10.1166/jnn.2018.14208
(2018)Doi:10.1039/a808170k
(1999)Doi:10.1016/S0960-894X(98)00181-4
(1998)Doi:10.1055/s-2002-31950
(2002)Doi:10.1039/b008159k
(2001)Doi:10.1016/S0040-4039(99)00049-0
(1999)